share_log

Meinian Onehealth Healthcare Holdings (SZSE:002044) Stock Falls 4.4% in Past Week as Five-year Earnings and Shareholder Returns Continue Downward Trend

Simply Wall St ·  Jun 23 22:18

Generally speaking long term investing is the way to go. But along the way some stocks are going to perform badly. For example, after five long years the Meinian Onehealth Healthcare Holdings Co., Ltd. (SZSE:002044) share price is a whole 62% lower. We certainly feel for shareholders who bought near the top. And some of the more recent buyers are probably worried, too, with the stock falling 41% in the last year. The falls have accelerated recently, with the share price down 23% in the last three months.

Since Meinian Onehealth Healthcare Holdings has shed CN¥700m from its value in the past 7 days, let's see if the longer term decline has been driven by the business' economics.

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

Meinian Onehealth Healthcare Holdings became profitable within the last five years. That would generally be considered a positive, so we are surprised to see the share price is down. Other metrics might give us a better handle on how its value is changing over time.

We don't think that the 0.5% is big factor in the share price, since it's quite small, as dividends go. In contrast to the share price, revenue has actually increased by 5.5% a year in the five year period. So it seems one might have to take closer look at the fundamentals to understand why the share price languishes. After all, there may be an opportunity.

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

earnings-and-revenue-growth
SZSE:002044 Earnings and Revenue Growth June 24th 2024

We know that Meinian Onehealth Healthcare Holdings has improved its bottom line lately, but what does the future have in store? If you are thinking of buying or selling Meinian Onehealth Healthcare Holdings stock, you should check out this free report showing analyst profit forecasts.

A Different Perspective

While the broader market lost about 14% in the twelve months, Meinian Onehealth Healthcare Holdings shareholders did even worse, losing 41% (even including dividends). However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 10% per year over five years. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. Before forming an opinion on Meinian Onehealth Healthcare Holdings you might want to consider these 3 valuation metrics.

Of course Meinian Onehealth Healthcare Holdings may not be the best stock to buy. So you may wish to see this free collection of growth stocks.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment